Michael M. Mueller
Keine laufenden Positionen mehr
Profil
Michael M.
Mueller served as Secretary, Vice President & General Counsel at Conatus Pharmaceuticals, Inc. He then worked as General Counsel & Vice President-Legal Affairs at Viracta Therapeutics, Inc. from 2020 to 2022.
Mueller holds an MBA from San Diego State University, an undergraduate degree from the University of Minnesota, and a graduate degree from Thomas Jefferson School of Law.
Ehemalige bekannte Positionen von Michael M. Mueller
| Unternehmen | Position | Ende |
|---|---|---|
| VIRACTA THERAPEUTICS, INC. | General Counsel | 01.01.2022 |
| HISTOGEN INC. | General Counsel | - |
Ausbildung von Michael M. Mueller
| University of Minnesota | Undergraduate Degree |
| Thomas Jefferson School of Law | Graduate Degree |
| San Diego State University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| VIRACTA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Conatus Pharmaceuticals, Inc.
 Conatus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Conatus Pharmaceuticals, Inc. is a biotechnology company that focuses on the development and commercialization of novel medicines to treat chronic diseases. The firm engages in developing emricasan, an orally active pan-caspase inhibitor, for the treatment of patients with chronic liver disease and is designed to reduce the activities of human caspases. It also develops CTS-2090, an orally active selective caspase inhibitor, for diseases involving inflammasome pathways. The company was founded by Alfred P. Spada, Jennifer Giottonini Cayer, and Steven J. Mento on July 13, 2005 and is headquartered in San Diego, CA. | Health Technology |
